Matthieu P K Crews1, Oliver D Howes. 1. South London and Maudsley NHS Foundation Trust, The Maudsley Hospital, Denmark Hill, London, SE5 8AZ, UK. Matthieu.Crews@slam.nhs.uk
Abstract
OBJECTIVE: Osteoporosis is increasingly common worldwide and there is a growing concern that the long-term use of antipsychotic medications increases the risk of this disorder. In this review, we consider whether antipsychotics may contribute to the development of osteoporosis through reductions in bone mineral density, discuss the possible mechanisms involved and consider the clinical implications of such a relationship. METHODS: We searched the literature for studies in this area published between 1966 and 2010 using the Medline and PubMed databases, supplemented by hand searches of retrieved reports. RESULTS: The available data indicate that statistically significant reductions in bone mineral density are frequently seen in patients prescribed with antipsychotic medications and suggest that there is a higher incidence of clinically significant reductions compared with the normal population. CONCLUSIONS: Clinicians should be aware for the potential negative effects of antipsychotic medications on bone mineral density, particularly in patients with additional risk factors for osteoporosis. Recommendations regarding routine monitoring of bone mineral density for patients prescribed antipsychotic medications cannot be made on the basis of existing evidence, and more research is required.
OBJECTIVE: Osteoporosis is increasingly common worldwide and there is a growing concern that the long-term use of antipsychotic medications increases the risk of this disorder. In this review, we consider whether antipsychotics may contribute to the development of osteoporosis through reductions in bone mineral density, discuss the possible mechanisms involved and consider the clinical implications of such a relationship. METHODS: We searched the literature for studies in this area published between 1966 and 2010 using the Medline and PubMed databases, supplemented by hand searches of retrieved reports. RESULTS: The available data indicate that statistically significant reductions in bone mineral density are frequently seen in patients prescribed with antipsychotic medications and suggest that there is a higher incidence of clinically significant reductions compared with the normal population. CONCLUSIONS: Clinicians should be aware for the potential negative effects of antipsychotic medications on bone mineral density, particularly in patients with additional risk factors for osteoporosis. Recommendations regarding routine monitoring of bone mineral density for patients prescribed antipsychotic medications cannot be made on the basis of existing evidence, and more research is required.
Authors: Jayashri Kulkarni; Anthony de Castella; Paul B Fitzgerald; Caroline T Gurvich; Michael Bailey; Cali Bartholomeusz; Henry Burger Journal: Arch Gen Psychiatry Date: 2008-08
Authors: U Halbreich; N Rojansky; S Palter; M Hreshchyshyn; J Kreeger; Y Bakhai; R Rosan Journal: Psychosom Med Date: 1995 Sep-Oct Impact factor: 4.312
Authors: Fenneke M van Hasselt; Paul F M Krabbe; Maarten J Postma; Anton J M Loonen Journal: Int J Methods Psychiatr Res Date: 2014-12-09 Impact factor: 4.035
Authors: Christine van der Leeuw; Sanne Peeters; Patrick Domen; Marinus van Kroonenburgh; Jim van Os; Machteld Marcelis Journal: PLoS One Date: 2015-08-26 Impact factor: 3.240